substance p has been researched along with Arterial Occlusive Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chien, CT; Lee, HM; Li, PC; Wu, CC | 1 |
| Donnerer, J; Lembeck, F | 1 |
| Matsuo, A; Shinoda, M; Toide, K | 1 |
| Bülow, JB; Fahrenkrug, J; Henriksen, JH; Schaffalitzky de Muckadell, O | 1 |
4 other study(ies) available for substance p and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Inhibitory effect of botulinum toxin type A on the NANC system in rat respiratory models of neurogenic inflammation.
Topics: Animals; Arterial Occlusive Diseases; Botulinum Toxins, Type A; Brain Stem; Capsaicin; Disease Models, Animal; Lung; Male; Neurogenic Inflammation; Neurotransmitter Agents; Pneumonia; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Substance P; Synaptosomal-Associated Protein 25 | 2012 |
Postocclusive cutaneous vasodilatation mediated by substance P.
Topics: Animals; Arterial Occlusive Diseases; Axons; Histamine Release; Male; Neurotransmitter Agents; Peripheral Nerves; Rats; Reflex; Skin; Substance P; Vasoactive Intestinal Peptide; Vasodilation | 1981 |
Pharmacological studies of a novel prolyl endopeptidase inhibitor, JTP-4819, in rats with middle cerebral artery occlusion.
Topics: Animals; Arginine Vasopressin; Arterial Occlusive Diseases; Avoidance Learning; Brain Ischemia; Cerebral Arteries; Cerebral Cortex; Hippocampus; Learning; Male; Maze Learning; Motor Activity; Protease Inhibitors; Pyrrolidines; Rats; Rats, Sprague-Dawley; Substance P; Thyrotropin-Releasing Hormone | 1996 |
Do substance P and vasoactive intestinal polypeptide (VIP) play a role in the acute occlusive or chronic ischaemic vasodilation in man?
Topics: Aged; Arterial Occlusive Diseases; Humans; Ischemia; Leg; Middle Aged; Substance P; Vasoactive Intestinal Peptide | 1986 |